The company states that each batch undergoes three separate rounds of testing at independent third-party laboratories: Testing Round 1 Identity Verification: According to the company, this confirms the product contains actual BPC-157 rather than filler or substitute compounds, using analytical techniques like mass spectrometry to verify the molecular structure matches authentic BPC-157
Emideltide, also called DSIP, was the only peptide rejected
Many report 5-15 pound muscle gains in the first 6 months with consistent training
In practice it is sold domestically only as an unregulated "research chemical" labeled not for human consumption, meaning purity, sterility, and labeled concentration are not verified by any regulatory body
No published human study tracks continuous use beyond 12 weeks, making extended unsupervised administration an undocumented risk with the current state of evidence on BPC-157
Human breast carcinoma (MCF-7) cells were procured from NCCS, Pune, India